Frontiers in Oncology | Breast Cancer

Original Research

Published on 01 Oct 2024

Vitamin D receptor is associated with prognostic characteristics of breast cancer after neoadjuvant chemotherapy—an observational study

in Breast Cancer

Joanna Streb
Agnieszka Łazarczyk
Przemysław Hałubiec
Anna Streb-Smoleń
Julita Ciuruś
Magdalena Ulatowska-Białas
Martyna Trzeszcz
Kamil Konopka
Diana Hodorowicz-Zaniewska
Joanna Szpor

Frontiers in Oncology

doi 10.3389/fonc.2024.1458124

1,987 views
4 citations

Original Research

Published on 30 Sep 2024

Safety and aesthetic outcomes of double purse-string suture nipple reconstruction in early breast cancer patients undergoing nipple resection and endoscopic skin-sparing mastectomy with breast reconstruction

in Breast Cancer

Hui Dai
Kawun Chung
Faqing Liang
Yanyan Xie
Qing Zhang
Mengxue Qiu
Huanzuo Yang
Jiao Zhou
Yu Feng

Frontiers in Oncology

doi 10.3389/fonc.2024.1462850

2,684 views
2 citations

Editorial

Published on 25 Sep 2024

Editorial: Advances in the treatment of hormonal receptor positive (HR+) breast cancer

in Breast Cancer

Wala Ben Kridis
Zheng Wang
Deniz Can Guven
Arunasalam Dharmarajan

Frontiers in Oncology

doi 10.3389/fonc.2024.1449566

1,563 views
1 citation

Original Research

Published on 25 Sep 2024

Efficacy and prognosis of neoadjuvant chemotherapy in HER2 low-expressing breast cancer: a retrospective single-center study

in Breast Cancer

Yarong Yao

Frontiers in Oncology

doi 10.3389/fonc.2024.1454726

1,546 views
2 citations

Original Research

Published on 25 Sep 2024

Results of the Italian cross-sectional web-based survey “Nutrition and breast cancer, what would you like to know?” An attempt to collect and respond to patients’ information needs, through social media

in Breast Cancer

Greta Caprara
Eleonora Pagan
Lucilla Titta
Maria Tieri
Giada Magionesi
Silvia Gallosti
Vincenzo Bagnardi
Ketti Mazzocco
Manuelita Mazza

Frontiers in Oncology

doi 10.3389/fonc.2024.1436610

2,913 views
2 citations

Case Report

Published on 24 Sep 2024

Case report: IORT as an alternative treatment option for breast cancer patients with difficulty staying still

in Breast Cancer

Fardeen Bhimani
Maureen McEvoy
Yu Chen
Anjuli Gupta
Jessica Pastoriza
Shani Fruchter
Zachary C. Bitan
Wolfgang A. Tomé
Keyur Mehta
Jana Fox

Frontiers in Oncology

doi 10.3389/fonc.2024.1429326

2,668 views
4 citations

Perspective

Published on 20 Sep 2024

Empowering precision medicine: regenerative AI in breast cancer

in Breast Cancer

Sudip Bhattacharya
Sheikh Mohd Saleem
Alok Singh
Sukhpreet Singh
Shailesh Tripathi

Frontiers in Oncology

doi 10.3389/fonc.2024.1465720

7,968 views
14 citations

Correction

Published on 19 Sep 2024

Corrigendum: Long-term oncologic outcomes following breast cancer surgery in adolescents and young adults: a single-center retrospective analysis

in Breast Cancer

Xin Liu
Zengyan Ma
Hongwu Chu
Weihong Nie
Guoxin Sun
Kaihua Zhao
Xiao Zou

Frontiers in Oncology

doi 10.3389/fonc.2024.1481345

1,010 views

Case Report

Published on 19 Sep 2024

BRCA2 mutations in familial breast cancer with prostate cancer: a case report and literature review

in Breast Cancer

Zhengsheng Liu
Qianhao Huang
Meixuan Ding

Frontiers in Oncology

doi 10.3389/fonc.2024.1428849

3,501 views
4 citations

Study Protocol

Published on 16 Sep 2024

Testing home-based exercise strategies in underserved minority cancer patients undergoing chemotherapy (THRIVE) trial: a study protocol

in Breast Cancer

Huimin Yan
Paola Gonzalo-Encabo
Rebekah L. Wilson
Cami N. Christopher
James D. Cannon
Dong-Woo Kang
John Gardiner
Michelle Perez
Mary K. Norris
Daniel Gundersen

Frontiers in Oncology

doi 10.3389/fonc.2024.1427046

3,968 views
2 citations

Original Research

Published on 16 Sep 2024

Lipid profiling of RON and DEK-dependent signaling in breast cancer guides discovery of gene networks predictive of poor outcomes

in Breast Cancer

Sara Vicente-Muñoz
James C. Davis
Adam Lane
Andrew N. Lane
Susan E. Waltz
Susanne I. Wells

Frontiers in Oncology

doi 10.3389/fonc.2024.1382986

3,137 views

Original Research

Published on 12 Sep 2024

2-methoxyestradiol inhibits the malignant behavior of triple negative breast cancer cells by altering their miRNome

in Breast Cancer

Ramadevi Subramani
Animesh Chatterjee
Diego A. Pedroza
Seeta Poudel
Preetha Rajkumar
Jeffrey Annabi
Elizabeth Penner
Rajkumar Lakshmanaswamy

Frontiers in Oncology

doi 10.3389/fonc.2024.1371792

3,167 views

Original Research

Published on 12 Sep 2024

Clinicopathological features, treatment patterns, and survival outcomes among Syrian patients with advanced breast cancer

in Breast Cancer

Muhammad Muhammad
Mousa Alali
Maher Saifo

Frontiers in Oncology

doi 10.3389/fonc.2024.1417053

4,045 views
2 citations

Original Research

Published on 06 Sep 2024

Topical treatment of chemotherapy-induced peripheral neuropathy (CIPN) with high-concentration (179 mg) capsaicin patch in breast cancer patients – results of the QUCIP study

in Breast Cancer

Michael Patrick Lux
Lilit Flöther
Catrin Frömter
Brigitte Rack
Kristina Veselinovic
Myriam Heine
Stefan Paepke
Petra Krabisch
Tamara Quandel
Rainer Sabatowski

Frontiers in Oncology

doi 10.3389/fonc.2024.1452099

5,241 views
5 citations

Original Research

Published on 02 Sep 2024

Clinical features and prognosis of parotid metastasis of breast cancer: retrospective analysis of 57 cases

in Breast Cancer

Fengli Guo
Honghai Fu
Yuhua Wang
Yitong Hua
Xiaohong Wang
Yingzhe Zhang

Frontiers in Oncology

doi 10.3389/fonc.2024.1442713

2,397 views
5 citations

Review

Published on 02 Sep 2024

New insights into acinic cell carcinoma of the breast: clinicopathology, origin of histology, molecular features, prognosis, and treatment

in Breast Cancer

Yunjie Ge
Xianping Wei
Jing-Nan Liu
Ping-Li Sun
Hongwen Gao

Frontiers in Oncology

doi 10.3389/fonc.2024.1438179

4,020 views
5 citations

Systematic Review

Published on 29 Aug 2024

Prognosis in HR-positive metastatic breast cancer with HER2-low versus HER2-zero treated with CDK4/6 inhibitor and endocrine therapy: a meta-analysis

in Breast Cancer

Lin-Yu Xia
Xu-Chen Cao
Qing-Lin Hu
Wei-Yun Xu

Frontiers in Oncology

doi 10.3389/fonc.2024.1413674

2,968 views
6 citations

Original Research

Published on 29 Aug 2024

Influence of H19 polymorphisms on breast cancer: risk assessment and prognostic implications via LincRNA H19/miR-675 and downstream pathways

in Breast Cancer

Ying Qi
Pengfei Zhao

Frontiers in Oncology

doi 10.3389/fonc.2024.1436874

2,281 views
2 citations

Original Research

Published on 29 Aug 2024

Expression profile of messenger and micro RNAs related to the histaminergic system in patients with five subtypes of breast cancer

in Breast Cancer

Tomasz Sirek
Agata Sirek
Marcin Opławski
Dariusz Boroń
Michał Chalcarz
Piotr Ossowski
Konrad Dziobek
Nikola Zmarzły
Damian Strojny
Beniamin Oskar Grabarek

Frontiers in Oncology

doi 10.3389/fonc.2024.1407538

2,712 views
7 citations

Original Research

Published on 21 Aug 2024

A novel x-Ray and γ-Ray combination strategy for radiotherapy after breast-conserving surgery in patients with right breast cancer

in Breast Cancer

Kunpeng Zhang
Ruixin He
Fenwen Tang
Luping Zhou
Xiaozhi Zhang
Jinsheng Li
Zhiwei Wei
Yi Li

Frontiers in Oncology

doi 10.3389/fonc.2024.1397273

2,035 views
2 citations

Original Research

Published on 21 Aug 2024

Pathological response and safety of albumin-bound paclitaxel as a neoadjuvant treatment for HER2-positive breast cancer compared to docetaxel combined with anti-HER2 therapy: a real-world study

in Breast Cancer

Zhidong Lyu
Linlin Gao

Frontiers in Oncology

doi 10.3389/fonc.2024.1412051

2,696 views
3 citations

Case Report

Published on 20 Aug 2024

Case report: A case of giant breast skin warts caused by HPV infection

in Breast Cancer

Chaohui Wang
Yuyang Zhao
Zhenhua Sun
Mingjun Li

Frontiers in Oncology

doi 10.3389/fonc.2024.1422800

3,055 views

Original Research

Published on 19 Aug 2024

Clinicopathologic significance of heat shock protein 60 as a survival predictor in breast carcinoma

in Breast Cancer

Qing Wang
Shengzhou Chen
Zhihong Wu
Jungang Ni

Frontiers in Oncology

doi 10.3389/fonc.2024.1415762

1,562 views

Case Report

Published on 16 Aug 2024

Expanding treatment options for patients with HER2+ metastatic breast cancer with margetuximab plus chemotherapy: a case report series

in Breast Cancer

Reshma Mahtani
Natasha Harpalani
Fengting Yan
Kristen Phiel
Iuliia Kovalenko

Frontiers in Oncology

doi 10.3389/fonc.2024.1419246

4,570 views
1 citation

1,700 articles

articles

Vitamin D receptor is associated with prognostic characteristics of breast cancer after neoadjuvant chemotherapy—an observational study

Safety and aesthetic outcomes of double purse-string suture nipple reconstruction in early breast cancer patients undergoing nipple resection and endoscopic skin-sparing mastectomy with breast reconstruction

Editorial: Advances in the treatment of hormonal receptor positive (HR+) breast cancer

Efficacy and prognosis of neoadjuvant chemotherapy in HER2 low-expressing breast cancer: a retrospective single-center study

Results of the Italian cross-sectional web-based survey “Nutrition and breast cancer, what would you like to know?” An attempt to collect and respond to patients’ information needs, through social media

Case report: IORT as an alternative treatment option for breast cancer patients with difficulty staying still

Empowering precision medicine: regenerative AI in breast cancer

Corrigendum: Long-term oncologic outcomes following breast cancer surgery in adolescents and young adults: a single-center retrospective analysis

BRCA2 mutations in familial breast cancer with prostate cancer: a case report and literature review

Testing home-based exercise strategies in underserved minority cancer patients undergoing chemotherapy (THRIVE) trial: a study protocol

Lipid profiling of RON and DEK-dependent signaling in breast cancer guides discovery of gene networks predictive of poor outcomes

2-methoxyestradiol inhibits the malignant behavior of triple negative breast cancer cells by altering their miRNome

Clinicopathological features, treatment patterns, and survival outcomes among Syrian patients with advanced breast cancer

Topical treatment of chemotherapy-induced peripheral neuropathy (CIPN) with high-concentration (179 mg) capsaicin patch in breast cancer patients – results of the QUCIP study

Clinical features and prognosis of parotid metastasis of breast cancer: retrospective analysis of 57 cases

New insights into acinic cell carcinoma of the breast: clinicopathology, origin of histology, molecular features, prognosis, and treatment

Prognosis in HR-positive metastatic breast cancer with HER2-low versus HER2-zero treated with CDK4/6 inhibitor and endocrine therapy: a meta-analysis

Influence of H19 polymorphisms on breast cancer: risk assessment and prognostic implications via LincRNA H19/miR-675 and downstream pathways

Expression profile of messenger and micro RNAs related to the histaminergic system in patients with five subtypes of breast cancer

A novel x-Ray and γ-Ray combination strategy for radiotherapy after breast-conserving surgery in patients with right breast cancer

Pathological response and safety of albumin-bound paclitaxel as a neoadjuvant treatment for HER2-positive breast cancer compared to docetaxel combined with anti-HER2 therapy: a real-world study

Case report: A case of giant breast skin warts caused by HPV infection

Clinicopathologic significance of heat shock protein 60 as a survival predictor in breast carcinoma

Expanding treatment options for patients with HER2+ metastatic breast cancer with margetuximab plus chemotherapy: a case report series